BioSpace News Archive

CynergisTek (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity and information assurance, today announced it began providing its new Biomedical Device Security Risk Assessment service to multiple health systems, including a large, 28-hospital health system.

SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, has partnered with Charles River Laboratories, which provides products and services that accelerate research and drug development efforts, to expand its small molecule screening collection and maximize its clients’ opportunities to discover hit compounds for their drug discovery projects.

AirXpanders, Inc., (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm Tissue Expander System, today announced it successfully closed in August 2018 its underwritten, pro rata, non-renounceable rights offering to raise approximately A$15.7 million

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has expanded the label for VENCLEXTA® (venetoclax tablets) in combination with rituximab to include information about patients with previously-treated chronic lymphocytic leukemia (CLL) who achieved minimal residual disease (MRD)-negativity in the Phase 3 MURANO trial.

Leaf Healthcare, maker of innovative patient monitoring technology, today announced the availability of an enhanced wireless patient sensor that enables nurses at the point of care to confirm the patient turn they just completed adequately protects against pressure injuries.

Technavio has announced their latest drug pipeline analysis report on hyperphosphatemia. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of hyperphosphatemia.

Evolve Formulas Introduces New Hemp-Derived Product to Indiana Market, Launching in Mid-September

NuVasive, Inc., (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Richard Vogel, Ph.D., DABNM, FASNM, director of Strategic Initiatives at NuVasive Clinical ServicesTM (NCS), will co-chair, moderate and lecture at the American Society of Neurophysiological Monitoring

Two papers report no hernia recurrences during postoperative period, highlight advantages in repair reinforcement and pain management.

This new strategic partnership will focus on the development of professional education programs, best-in-class services, and industry platforms.